Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
NURE-Combo trial: what clinicians have said so far
An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)
- NCT04876313 ↗
- Unknown
- IRCCS San Raffaele
- Deep size, estimated: 301+ verified statements once built
We haven't built an HCP commentary report on NURE-Combo (nivolumab plus nab-paclitaxel in muscle-invasive bladder cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NURE-Combo so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 43 posts on X, typically up to 189 once built | |
| 2 YouTube videos, typically up to 9 once built |
The trial
ClinicalTrials.gov- Official title
- An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer
- Phase
- Phase 2
- Status
- Unknown
- Conditions
- Muscle-Invasive Bladder Carcinoma
- Interventions
- Nivolumab + Nab-paclitaxel; Nivolumab
- Arms
- Combined Drugs · Experimental
- Enrollment
- 29 (estimated)
- Primary outcomes
- Pathological complete response
- Sponsor
- IRCCS San Raffaele with Bristol-Myers Squibb
- Start
- Jan 27, 2022
- Primary completion
- Dec 2024 (estimated)
- Results posted
- No
- Registry record
- NCT04876313 · updated Apr 6, 2022
Publications
linked from the registry- Mercinelli C, Moschini M, Cigliola A, Mattorre B, Tateo V, Basile G, Cogrossi LL, Maiorano BA, Patane DA, Raggi D, Pastorino GL, Re C, Colecchia M, Luciano R, Colombo R, Brembilla G, De Cobelli F, Briganti A, Pavlick DC, Ross JS, Montorsi F, Bellone M, Necchi A. First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer. J Clin Oncol. 2024 Dec 10;42(35):4196-4205. doi: 10.1200/JCO.24.00576. Epub 2024 Sep 6. PubMed 39241203